Pharmaceutical Executive
March 12, 2012
Features
0
0
With growth as its guiding light, Novartis has big plans for the emerging markets. Pharm Exec sits down with CEO Joe Jimenez to understand what it will take the company to best the competition.
March 01, 2012
Issue PDF
0
0
Leading in Emerging Markets
March 01, 2012
Regulatory
0
0
How can we better balance addressing medical needs with ensuring that new drugs are safe and effective? Ron Cohen reports.
March 01, 2012
European Report
0
0
After his predecessor and countryman left the EMA in disgrace, Guido Rasi jumps in as executive director-with great challenges ahead.
March 01, 2012
Features
0
0
Our annual press audit finds that the big news in 2011 for pharma was ... no news.
March 01, 2012
From the Editor
0
0
Pharm Exec's latest EAB meeting offered a frank exchange on this magazine's digital future.
March 01, 2012
Features
0
0
Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma
March 01, 2012
Marketing
0
0
Pharmaceutical trade dres is an effective marketing tool that helps boost product recognition for consumers. It's worth protecting.
March 01, 2012
Column
0
0
FDA and industry are pushing user fees, while they struggle with curbs on communications.
March 01, 2012
Back Page
0
0
In the rush to collect as much patient data as possible, are we sacrificing quality for quantity? Ben Comer reports.